NTLA Cash & Equivalents
Intellia Therapeutics Inc · Cash & Equivalents
NTLA Cash & Equivalents
Latest reported$155.46Mperiod ending
NTLA FY Cash & Equivalents ($9.85M → $155.46M)
Annual Cash & Equivalents
High-resolution chart · PNG
NTLA cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 155,464,000 | |
| 189,182,000 | |
| 226,748,000 | |
| 523,506,000 | |
| 123,406,000 | |
| 160,020,000 | |
| 57,226,000 | |
| 58,856,000 | |
| 340,678,000 | |
| 273,064,000 | |
| 75,816,000 | |
| 9,845,000 |